AGC

Angelo Gordon & Co Portfolio holdings

AUM $1.06B Turnover 38.96%
1-Year Est. Return 47.95%
This Fund
S&P 500
This Quarter Est. Return
+2.94%
1 Year Est. Return
+47.95%
3 Year Est. Return
+90.06%
5 Year Est. Return
+125.11%
10 Year Est. Return
+345.29%
AUM
$647M
AUM Growth
-$136M
Cap. Flow
-$260M
Cap. Flow %
-40.22%
Top 10 Hldgs %
68.55%
Holding
92
New
16
Increased
4
Reduced
5
Closed
23
Avg Time Held Equity + Options
0.8 years
Top 10 Avg Time Held Equity + Options
0.8 years
Top 20 Avg Time Held Equity + Options
0.6 years
Avg Time Held Equity only
0.8 years
Top 10 Avg Time Held Equity only
0.8 years
Top 20 Avg Time Held Equity only
0.6 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 39.81%
2 Utilities 17.47%
3 Healthcare 14.96%
4 Energy 14.7%
5 Communication Services 5.76%

Similar funds

Angelo Gordon & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Angelo Gordon & Co held 92 positions worth $647M, down 17% from $784M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Angelo Gordon & Co withdrew a net $260M in Q4 2019, closing 23 positions and reducing 5 holdings. Its most notable exit was Celgene Corp, an estimated $29.8M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, up from 38% a quarter earlier, followed by Utilities and Healthcare.

Against the trend, Angelo Gordon & Co opened a new position in Wright Medical Group Inc worth $10.8M.

  • Angelo Gordon & Co's largest Q4 2019 buy was Wright Medical Group Inc: 355,200 shares worth $10.8M.
  • Angelo Gordon & Co added most to Hovnanian Enterprises in Q4 2019, an estimated $2.11M increase.
  • Angelo Gordon & Co's biggest Q4 2019 reduction was Energy Transfer Partners, cutting an estimated $16.5M.
  • Angelo Gordon & Co fully exited Celgene Corp in Q4 2019, selling an estimated $29.8M.
  • Angelo Gordon & Co's ten largest holdings make up 69% of its $647M portfolio in Q4 2019.
  • Angelo Gordon & Co opened 16 new positions and closed 23 in Q4 2019.
  • Angelo Gordon & Co's portfolio value fell 17% quarter-over-quarter to $647M.

Based on Angelo Gordon & Co's 13F filing for Q4 2019, filed 14 Feb 2020.